Experimental and clinical evaluation of cancer immunotherapeutics.
作者信息
Azuma I, Sakurai Y
出版信息
Cancer Treat Rev. 1981 Sep;8(3):191-5. doi: 10.1016/s0305-7372(81)80016-3.
PMID:7030486
Abstract
摘要
相似文献
1
Experimental and clinical evaluation of cancer immunotherapeutics.癌症免疫疗法的实验与临床评估
Cancer Treat Rev. 1981 Sep;8(3):191-5. doi: 10.1016/s0305-7372(81)80016-3.
2
[Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].卡介苗及其衍生物的癌症免疫疗法——临床试验（作者译）
Kekkaku. 1980 Aug;55(8):359-63.
3
[A review on mechanism of anti-tumor action of BCG (author's transl)].[卡介苗抗肿瘤作用机制的综述（作者译）]
Kekkaku. 1980 Aug;55(8):351-7.
4
BCG and cancer (first of two parts).卡介苗与癌症（两部分中的第一部分）
N Engl J Med. 1974 Jun 20;290(25):1413-20. doi: 10.1056/NEJM197406202902506.
5
Active immunotherapy of cancer for minimal residual disease: new trends and new materials.癌症微小残留病的主动免疫治疗：新趋势与新材料
Prog Exp Tumor Res. 1980;25:242-74. doi: 10.1159/000403185.
6
An experimental model for immunotherapy of cancer.一种癌症免疫疗法的实验模型。
Natl Cancer Inst Monogr. 1973 Dec;39:3-9.
7
Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines.使用卡介苗-肿瘤细胞疫苗进行癌症主动特异性免疫治疗的基本原理。
Prog Clin Biol Res. 1989;310:51-65.
8
The choice of animal tumors for experimental studies of cancer therapy.
Adv Cancer Res. 1978;27:149-200. doi: 10.1016/s0065-230x(08)60932-x.
9
Role of BCG immunotherapy in malignant disease.
South Med J. 1975 Jun;68(6):673-5. doi: 10.1097/00007611-197506000-00002.
10
The balance of host immunocompetence in chemical carcinogenesis and "nonspecific" immunotherapy.化学致癌作用中宿主免疫能力的平衡与“非特异性”免疫治疗
Recent Results Cancer Res. 1975(52):114-36. doi: 10.1007/978-3-642-80940-8_14.
Zotero 插件